| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|
| Net revenues | 3,012,904 | 7,790,865 | 10,863,443 | |
| Cost of net revenues | 2,781,892 | 7,285,113 | 10,170,802 | |
| Gross profit | 231,012 | 505,752 | 692,641 | |
| General and administrative | 30,172,800 | 4,859,949 | 31,172,920 | |
| Sales and marketing | 803,747 | 343,383 | 65,217 | |
| Depreciation and amortization | 802,794 | 802,796 | 802,872 | |
| Total operating expenses | 31,779,341 | 6,006,128 | 32,041,009 | |
| Loss from operations | -31,548,329 | -5,500,376 | -31,348,368 | |
| Interest expense, net | 1,425,307 | 1,184,040 | 1,094,490 | |
| Loss on debt extinguishment | -1,353,663 | - | - | |
| Other income | 9,095 | 11,952 | 11,955 | |
| Total other expense, net | -2,769,875 | -1,172,088 | -1,082,535 | |
| Net loss before income taxes | -34,318,204 | -6,672,464 | -32,430,903 | |
| Provision for income taxes | - | 0 | - | |
| Net loss | -34,318,204 | -6,672,464 | -32,430,903 | |
| Net loss per common share - basic | -0.46 | -0.11 | -0.62 | |
| Net loss per common share - diluted | -0.46 | -0.11 | -0.62 | |
| Weighted average common shares outstanding - basic | 74,379,403 | 61,771,127 | 51,916,787 | |
| Weighted average common shares outstanding - diluted | 74,379,403 | 61,771,127 | 51,916,787 | |
Wellgistics Health, Inc. (WGRX)
Wellgistics Health, Inc. (WGRX)